Performance labs for men: The blood tests and biomarkers that matter

For men, the performance labs that matter most are morning blood tests that can explain symptoms and guide action, especially total testosterone below 350 ng/dL, free testosterone below 100 pg/mL, and the LH plus FSH pattern that shows whether the problem starts in the testes or higher in the hormone axis. Add practical biomarkers such as CBC, Comprehensive Metabolic Panel, estradiol, PSA after age 40, and trend data from wearables, and health monitoring becomes useful instead of obsessive.

Key takeaways

• A hormone workup is most informative when blood tests are drawn between 07:00 and 11:00, and Veedma uses 350 ng/dL for total testosterone and 100 pg/mL for free testosterone as decision thresholds when symptoms persist.^[2]
• LH and FSH are mandatory alongside testosterone because high LH plus low testosterone points to primary hypogonadism, while low or normal LH plus low testosterone suggests secondary or functional hypogonadism. Men with LH below 8 mIU/mL may be candidates for Enclomiphene rather than defaulting to TRT.
• Consumer wearables are useful for trends in heart rate, step count, and training load, but systematic reviews show they are less dependable for calorie burn and sleep stage detail than many users assume.^{[5] [6]}
• In one survey of more than 700 men in an online health community, the respondents in that specific community reported that nearly three quarters tracked health data, nearly 80 percent tracked lab results, and 70 percent said the numbers changed their diet, training, or supplement choices.
• A landmark clinic study found hypogonadotropic hypogonadism in about one third of men with type 2 diabetes, which is one reason performance labs should include metabolic blood tests and not just gym metrics.^[7]

Why performance labs matter

Performance labs matter because blood tests and wearables measure different parts of the same system. Blood biomarkers show what is happening inside the body at the molecular level, while wearables capture day to day output such as resting heart rate, sleep time, pace, and estimated VO2 max.

For men, that distinction matters most when symptoms do not match the surface data. A man can still hit his steps, close his rings, and train four days a week while losing libido, morning erections, strength, or recovery. In the European Male Ageing Study, late onset hypogonadism was defined by low testosterone plus sexual symptoms, not by a low lab number alone.^[1] According to the Endocrine Society guideline, male hypogonadism is a clinical syndrome that requires both persistent symptoms and biochemical evidence.^[2]

The appetite for health monitoring is clearly rising. A recent survey of more than 700 men in one online health community described the habits of that specific group: nearly three quarters tracked health data, 22 percent said they were deeply invested, nearly 80 percent tracked lab results, 48 percent tracked sleep and recovery, and 45 percent tracked calories, macros, or micronutrients. But more data is not automatically better. A 2015 systematic review found that consumer wearables perform best for step counting and basic activity tracking, while a 2019 meta analysis found that sleep estimates from wrist devices can look polished but still miss important detail compared with formal sleep testing.^{[5] [6]}

Which biomarkers belong in performance labs

The right performance labs for men focus on hormone signaling, metabolic health, and safety markers that can actually change decisions.

Testosterone and free testosterone

Total testosterone and free testosterone are the cornerstone blood tests when a man has low libido, erection changes, fatigue, loss of strength, or poor recovery. Free testosterone is the fraction of testosterone not tightly bound to proteins and available to tissues, and Veedma prioritizes direct measurement by Equilibrium Dialysis with LC MS/MS because many routine immunoassays are less accurate, especially at the edges of the range.^{[2] [3]}

Timing matters. According to the Endocrine Society guideline, testosterone should be measured in the morning, and Veedma uses a draw between 07:00 and 11:00, with 350 ng/dL for total testosterone and 100 pg/mL for free testosterone as treatment thresholds when symptoms persist.^[2]

LH and FSH

LH and FSH are gonadotropins, which means pituitary signals that tell the testes to produce testosterone and support sperm production. Without LH and FSH, you cannot classify primary versus secondary hypogonadism, and that means you cannot choose the correct treatment path.^[2]

High LH plus low testosterone suggests primary hypogonadism, where the testes are failing to respond. Low or normal LH plus low testosterone suggests secondary or functional hypogonadism, where the signaling is suppressed higher up the axis. For men with symptoms, low testosterone, and LH below 8 mIU/mL, Enclomiphene is often the first line option because it stimulates the body to raise LH rather than replacing testosterone from the outside.

Estradiol, prolactin, and thyroid when needed

Estradiol is a form of estrogen that men also make, mainly by converting testosterone in fat tissue, and it still matters for libido, erectile function, and bone health. Prolactin is a pituitary hormone that can suppress GnRH, the brain signal that starts the testosterone cascade, so it becomes especially relevant when testosterone is low and LH and FSH are not appropriately elevated.^[2]

TSH, the main thyroid screening marker, is not mandatory for every man, but it is clinically indicated when fatigue, weight change, mood symptoms, or unexplained low energy suggest a thyroid issue. This is why strong performance labs are targeted. They are not random biomarker shopping.

Safety and performance markers beyond hormones

Performance labs should also include safety markers that explain why a man feels worse, recovers poorly, or may not be a candidate for certain treatments. Veedma’s core panel includes CBC, Comprehensive Metabolic Panel, vitamin D, PSA for men age 40 and older, and fasting insulin when BMI is greater than 25. When clinically indicated, the medical team may also add a lipid panel, prolactin, or thyroid testing.

CBC measures blood cells, and it matters because androgen based treatment can raise hematocrit. The Comprehensive Metabolic Panel checks liver enzymes, kidney function, electrolytes, and glucose related clues. In men with type 2 diabetes, low testosterone is common enough that ignoring metabolic blood tests can miss the real reason a man’s performance is slipping.^[7] Veedma does not order SHBG as a separate test because direct free testosterone by Equilibrium Dialysis already answers the question more cleanly.

What wearables can and cannot tell you

Wearables are best for trend spotting, not diagnosis. A 2015 systematic review found that consumer devices were generally strongest for step counts and activity, while accuracy for energy expenditure was weaker and more variable across brands and settings.^[5]

Sleep data has similar limits. A 2019 meta analysis of Fitbit wrist devices found reasonable sensitivity for detecting sleep versus wake, but weaker specificity, which means the device may overcall sleep and underdetect wakefulness.^[6] That makes a wearable helpful for long term health monitoring, but not a substitute for blood tests, a sleep study, or a clinical evaluation.

What abnormal biomarkers can point to

Abnormal performance labs can point to metabolic disease, pituitary signaling problems, testicular failure, sleep related strain, and higher cardiovascular risk.

Type 2 diabetes and insulin resistance. According to a landmark clinic study in men with type 2 diabetes, 33 percent had hypogonadotropic hypogonadism.^[7] In practice, that means low testosterone can be a metabolic warning sign, not just a sex hormone issue. Men with more abdominal fat, higher fasting insulin, and worse glucose control are also more likely to show the low or normal LH pattern typical of functional suppression.

Primary versus secondary hypogonadism. This is why LH and FSH matter. High LH with low testosterone suggests the testes are not responding. Low or normal LH with low testosterone suggests the brain is not sending a strong enough signal. The fix is not the same in both cases, and a low number alone cannot tell you which pathway you are dealing with.^[2]

Cardiovascular risk. A meta analytic study linked hypogonadism in men with higher cardiovascular mortality, though low testosterone is often traveling with obesity, diabetes, inflammation, and low fitness rather than acting alone.^[8] That is one reason strong health monitoring includes blood pressure, lipids when indicated, glucose related markers, and training capacity, not just hormone biomarkers.

Fertility and sexual health. Low testosterone with abnormal LH or FSH can accompany impaired sperm production, lower libido, and erectile problems. It also changes treatment choices. TRT suppresses gonadotropins and spermatogenesis and is contraindicated in men actively seeking fertility.^[2] By contrast, Enclomiphene can raise endogenous testosterone in men with secondary or functional hypogonadism while preserving testicular function.

Signs your health monitoring is finding something real

Repeated patterns matter more than a single bad day, especially when symptoms line up with abnormal blood tests or a clear drift in wearable data.^{[1] [2]}

• You are sleeping about the same number of hours, but your resting heart rate is running 5 to 10 beats per minute above baseline for more than a week and workouts feel harder at the same pace.
• Your libido is down for several weeks, not just after one stressful work stretch, and morning erections are less frequent or weaker than your usual baseline.
• Your body weight is stable, but your waist is growing, your lifts are stalling, and recovery between hard sessions is worse despite similar protein and calorie intake.
• Your estimated VO2 max or pace at a familiar heart rate is dropping over a month or two, and the decline is paired with lower motivation, poorer sleep quality, or more afternoon fatigue.
• You are feeling mentally flat, less assertive, or more irritable, and the change arrived with lower sex drive and slower gym progress rather than as a pure mood issue.
• Your smartwatch keeps flagging poor recovery, but what gets your attention is what you notice in real life. Less drive, less morning energy, less training pop, and more brain fog.
• You have erection changes or reduced ejaculate volume along with lower desire, especially if you are also dealing with obesity, diabetes, sleep apnea, or certain medications.
• You have been adding supplements every few weeks to fix fatigue, but you have never had a targeted set of blood tests to check hormones, metabolic strain, liver function, or blood counts.

Myth vs fact

Myth: More biomarkers always make better performance labs

Fact: A targeted panel beats a giant untargeted panel. Male hypogonadism requires symptoms plus biochemical evidence, and LH and FSH are essential because they classify the problem. A huge list of numbers cannot compensate for missing the few that actually change diagnosis and treatment.^{[1] [2]}

Myth: Wearables can diagnose hormone problems

Fact: Wearables can flag trends, but they do not diagnose endocrine disorders. Systematic reviews show reasonable performance for activity tracking and decent sleep detection in some devices, but weaker accuracy for energy expenditure and sleep stage detail.^{[5] [6]}

Myth: A normal total testosterone means you are definitely fine

Fact: Not always. Free testosterone can reveal a clinically relevant problem even when total testosterone looks less alarming, which is why direct measurement matters. According to the Endocrine Society guideline, reliable assays are critical, and older immunoassays can disagree substantially with mass spectrometry methods.^{[2] [3]}

Myth: TRT is the standard fix for any low testosterone result

Fact: TRT is reserved for documented hypogonadism, especially primary hypogonadism or secondary hypogonadism that does not respond to Enclomiphene. It suppresses gonadotropins and spermatogenesis, so it is the wrong choice for many men who want fertility. A 2023 New England Journal of Medicine trial in 5,246 men found TRT was noninferior to placebo for major cardiovascular events over a mean follow up of 33 months, but that does not make it an optimization tool for men with normal testosterone.^{[2] [4]}

How to use performance labs without obsessing

The smartest way to use performance labs is to test with a question, match the numbers to symptoms, and repeat only when the result could change what you do next.

1. Step 1: Start with a real baseline. Get morning blood tests between 07:00 and 11:00 before changing three supplements at once. For hormone symptoms, that means total testosterone by LC MS/MS, free testosterone by Equilibrium Dialysis with LC MS/MS, LH, FSH, estradiol, CBC, Comprehensive Metabolic Panel, vitamin D, PSA if you are 40 or older, and fasting insulin if BMI is greater than 25.
2. Step 2: Pair your blood tests with 30 days of simple health monitoring. Track sleep duration, resting heart rate, body weight, waist size, training output, libido, erection quality, and energy. If total testosterone is below 350 ng/dL or free testosterone is below 100 pg/mL with persistent symptoms, abnormal testosterone results are typically confirmed with a second morning blood draw before diagnosing hypogonadism or starting treatment. The next question is classification. High LH points toward primary hypogonadism. Low or normal LH points toward secondary or functional hypogonadism. When LH is below 8 mIU/mL and the picture fits, Enclomiphene can be first line because it increases the body’s own LH signaling and preserves fertility.
3. Step 3: Retest on a schedule, not on impulse. After treatment starts, Veedma recommends follow up labs after the first month, then every 6 months. The goal is not constant tweaking. It is to see whether symptoms, biomarkers, and day to day performance are moving in the same direction.

Veedma is a preventive men’s health clinic, not a TRT clinic. The medical team offers a thorough diagnostic workup with an advanced lab panel measured by LC MS/MS, or a review of existing lab results, including uploads from services like Function Health. From there, licensed providers build individualized treatment plans, with Enclomiphene as the first line option for secondary and functional hypogonadism, and the Enclomiphene plus Tadalafil combination tablet when erection or urinary symptoms are also present. Ongoing monitoring and protocol adjustments are built into the process.

The bottom line on performance labs for men

The blood tests and biomarkers that matter most for men are the ones that explain symptoms and change decisions: morning total testosterone, directly measured free testosterone, LH, FSH, estradiol, CBC, Comprehensive Metabolic Panel, vitamin D, PSA when age appropriate, and insulin when body composition suggests metabolic strain. Wearables are valuable for trend tracking, but the real work of diagnosis still happens in the blood.

References

1. Wu FC, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. The New England journal of medicine. 2010;363:123-35. PMID: 20554979
2. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism. 2018;103:1715-1744. PMID: 29562364
3. Bizuneh AD, Joham AE, Teede H, et al. Evaluating the diagnostic accuracy of androgen measurement in polycystic ovary syndrome: a systematic review and diagnostic meta-analysis to inform evidence-based guidelines. Human reproduction update. 2025;31:48-63. PMID: 39305127
4. Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular Safety of Testosterone-Replacement Therapy. The New England journal of medicine. 2023;389:107-117. PMID: 37326322
5. Evenson KR, Goto MM, Furberg RD. Systematic review of the validity and reliability of consumer-wearable activity trackers. The international journal of behavioral nutrition and physical activity. 2015;12:159. PMID: 26684758
6. Haghayegh S, Khoshnevis S, Smolensky MH, et al. Accuracy of Wristband Fitbit Models in Assessing Sleep: Systematic Review and Meta-Analysis. Journal of medical Internet research. 2019;21:e16273. PMID: 31778122
7. Defeudis G, Mazzilli R, Tenuta M, et al. Erectile dysfunction and diabetes: A melting pot of circumstances and treatments. Diabetes/metabolism research and reviews. 2022;38:e3494. PMID: 34514697
8. Corona G, Rastrelli G, Monami M, et al. Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. European journal of endocrinology. 2011;165:687-701. PMID: 21852391